DaVita Inc.

PagerDuty Announces Fourth Quarter and Full Year Fiscal 2024 Financial Results

Retrieved on: 
Thursday, March 14, 2024

PagerDuty will host a conference call and live webcast for analysts and investors at 2:00 p.m. Pacific Time on March 14, 2024.

Key Points: 
  • PagerDuty will host a conference call and live webcast for analysts and investors at 2:00 p.m. Pacific Time on March 14, 2024.
  • This news release with the financial results will be accessible from PagerDuty’s website at investor.pagerduty.com prior to the conference call.
  • Supplemental Financial and Other Information:
    Supplemental financial and other information can be accessed through PagerDuty’s investor relations website at investor.pagerduty.com.
  • Specifically, PagerDuty excludes the following from its historical and prospective non-GAAP financial measures, as applicable:
    Stock-based Compensation: PagerDuty utilizes stock-based compensation to attract and retain employees.

Former DaVita IKC General Counsel Stephen Bentfield Joins Crowell & Moring

Retrieved on: 
Wednesday, April 3, 2024

Bentfield's practice will focus on fraud and abuse matters, organizational compliance programs and policies, and managed care. He will advise clients on value-based care -- an emerging priority in the health care industry that is focused on quality of care, provider performance, and the patient experience. In addition, his practice will encompass health care regulatory issues, including reimbursement for care, licensure, and state regulatory issues. Bentfield has extensive experience drafting contracts, advising on deal structuring and negotiation, including the creation of joint ventures and other new corporate structures, as well as mergers and acquisitions.

Key Points: 
  • DENVER, April 3, 2024 /PRNewswire/ -- Stephen Bentfield , former vice president and group general counsel at DaVita Integrated Kidney Care, has joined Crowell & Moring's Health Care Group as a partner in the Denver office, expanding the firm's regulatory and transactional depth in the health care industry.
  • In addition, his practice will encompass health care regulatory issues, including reimbursement for care, licensure, and state regulatory issues.
  • "His in-house experience at DaVita gives Stephen a unique perspective into the nuanced art of balancing business objectives with legal and regulatory risk mitigation.
  • I am excited to contribute these skills to deepen the firm's health care regulatory and transactional bench."

The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On

Retrieved on: 
Monday, March 11, 2024

DENVER, March 11, 2024 /PRNewswire/ -- Today, The American Diabetes Association ® (ADA) and DaVita (NYSE: DVA), a leading provider of kidney care services, announced the expansion of a multi-year collaboration, focused on advancing chronic disease prevention, specifically addressing two of the most prevalent chronic conditions in the U.S. — diabetes and chronic kidney disease (CKD). The kick-off for this expanded effort coincides with National Kidney Month, a time when both organizations bolster efforts to increase kidney health awareness and education.

Key Points: 
  • Efforts to advance chronic disease prevention through enhanced education, awareness and support — kicking off during National Kidney Month
    DENVER, March 11, 2024 /PRNewswire/ -- Today, The American Diabetes Association ® (ADA) and DaVita (NYSE: DVA), a leading provider of kidney care services, announced the expansion of a multi-year collaboration, focused on advancing chronic disease prevention, specifically addressing two of the most prevalent chronic conditions in the U.S. — diabetes and chronic kidney disease (CKD).
  • Chronic disease is the leading cause of death and disability in the United States.
  • [1] More than 38 million Americans are living with diabetes, and approximately one in three American adults with diabetes has CKD.
  • On March 26, DaVita dietitians will join the ADA for a live cooking class featuring a tasty diabetes- and kidney-friendly meal.

DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador

Retrieved on: 
Tuesday, March 5, 2024

DENVER, March 5, 2024 /PRNewswire/ -- DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today announced that it has agreed to terms on the expansion of its international operations in Brazil and Colombia, and its entry into Chile and Ecuador. The deal, which is consistent with DaVita's disciplined investment strategy, involves four separate acquisitions from Fresenius Medical Care for a total purchase price of $300M USD. The transaction in Chile closed effective today. The transactions in Ecuador, Colombia and Brazil remain subject to each country's respective anti-trust and regulatory approval processes, which are each expected to be completed at various times during 2024.

Key Points: 
  • The deal, which is consistent with DaVita's disciplined investment strategy, involves four separate acquisitions from Fresenius Medical Care for a total purchase price of $300M USD.
  • The transaction in Chile closed effective today.
  • The transactions in Ecuador, Colombia and Brazil remain subject to each country's respective anti-trust and regulatory approval processes, which are each expected to be completed at various times during 2024.
  • We look forward to building on our existing market expertise and the established quality of these centers through this transition."

DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador

Retrieved on: 
Tuesday, March 5, 2024

DENVER, March 5, 2024 /PRNewswire/ -- DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today announced that it has agreed to terms on the expansion of its international operations in Brazil and Colombia, and its entry into Chile and Ecuador. The deal, which is consistent with DaVita's disciplined investment strategy, involves four separate acquisitions from Fresenius Medical Care for a total purchase price of $300M USD. The transaction in Chile closed effective today. The transactions in Ecuador, Colombia and Brazil remain subject to each country's respective anti-trust and regulatory approval processes, which are each expected to be completed at various times during 2024.

Key Points: 
  • The deal, which is consistent with DaVita's disciplined investment strategy, involves four separate acquisitions from Fresenius Medical Care for a total purchase price of $300M USD.
  • The transaction in Chile closed effective today.
  • The transactions in Ecuador, Colombia and Brazil remain subject to each country's respective anti-trust and regulatory approval processes, which are each expected to be completed at various times during 2024.
  • We look forward to building on our existing market expertise and the established quality of these centers through this transition."

Vail Resorts Appoints Julie DeCecco as General Counsel

Retrieved on: 
Thursday, February 15, 2024

BROOMFIELD, Colo., Feb. 15, 2024 /PRNewswire/ -- Vail Resorts, Inc. (NYSE: MTN) today announced that Julie DeCecco, the company's current deputy general counsel and vice president, has been appointed general counsel and executive vice president.

Key Points: 
  • BROOMFIELD, Colo., Feb. 15, 2024 /PRNewswire/ -- Vail Resorts, Inc. (NYSE: MTN) today announced that Julie DeCecco, the company's current deputy general counsel and vice president, has been appointed general counsel and executive vice president.
  • DeCecco joined Vail Resorts in 2017 as associate general counsel and was promoted to deputy general counsel in 2018.
  • As Vail Resorts' general counsel, DeCecco will oversee legal, governance, compliance, internal audit, health and safety, and real estate.
  • Prior to Vail Resorts, DeCecco was associate general counsel for DaVita and chief litigation counsel at Sun Microsystems (now Oracle), where she played a critical role on more than 25 acquisitions.

The Thurman Group Announces 2024 Launch: Your Trusted Strategic Partner in Media Training and Issues Management

Retrieved on: 
Monday, February 5, 2024

The Thurman Group today announced its launch, offering unparalleled expertise in media training and issues management to empower organizations across industries to navigate the dynamic and ever-evolving media landscape with confidence and resilience.

Key Points: 
  • The Thurman Group today announced its launch, offering unparalleled expertise in media training and issues management to empower organizations across industries to navigate the dynamic and ever-evolving media landscape with confidence and resilience.
  • Led by seasoned communications executive James “Skip” Thurman, The Thurman Group brings decades of experience advising and coaching senior executives across diverse sectors including media, healthcare, telecommunications, and higher education.
  • “At The Thurman Group, we are dedicated to empowering our clients to face the spotlight with poise and purpose,” said Skip Thurman, co-founder and CEO of The Thurman Group.
  • For more information about The Thurman Group and its services, please visit www.skipthurman.com or contact The Thurman Group directly.

Apollo Medical Holdings, Inc. Announces Leadership Transitions

Retrieved on: 
Wednesday, January 24, 2024

Dr. Dinesh Kumar will be joining the executive team as Chief Medical Officer of ApolloMed, effective January 23, 2024.

Key Points: 
  • Dr. Dinesh Kumar will be joining the executive team as Chief Medical Officer of ApolloMed, effective January 23, 2024.
  • Prior to his appointment as CMO of ApolloMed, Dr. Kumar served as Chief Medical and Chief Operating Officer at Alignment Healthcare.
  • Dr. Kumar received his medical degree from the University of Madras and completed his residency in internal medicine at Howard University.
  • He then completed his fellowship in pulmonary and critical care medicine at Harbor-UCLA Medical Center and completed a Health Care Leadership Program at the University of California-San Francisco.

DaVita Inc. Schedules 4th Quarter 2023 Investor Conference Call

Retrieved on: 
Tuesday, January 23, 2024

DENVER, Jan. 23, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Tuesday, February 13, 2024, at 5:00 p.m. Eastern Time.

Key Points: 
  • DENVER, Jan. 23, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Tuesday, February 13, 2024, at 5:00 p.m. Eastern Time.
  • The company plans to release its results after market close the same day.
  • This call is also being webcast and can be accessed at the DaVita IR web page.
  • Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com.

CORE Kidney's “Gift of Life: A Tune That Never Fades” Float Wins the Hearts of Rose Parade® Crowd, Recognized With 2024 Isabella Coleman Award

Retrieved on: 
Tuesday, January 16, 2024

A special thanks to Lyn Lofthouse for the floral decorations that won us the Isabella Coleman Award.

Key Points: 
  • A special thanks to Lyn Lofthouse for the floral decorations that won us the Isabella Coleman Award.
  • We are also very grateful to Steve Perry and the Tournament of Roses team for supporting us all along.
  • The float with the kidney-shaped tree sat living kidney donors, kidney health champions, in a beautiful colorful garden as they danced to, “Dancing in the Streets” tune!
  • CORE Kidney’s Rose Parade float was sponsored by Amgen, Baxter International, DaVita and Travere Therapeutics, who made it possible to feature living kidney donors on the float.